Literature DB >> 3944746

Antibody response in serum and intestine in children up to six months after a naturally acquired rotavirus gastroenteritis.

K Hjelt, P C Grauballe, L Andersen, P O Schiøtz, P Howitz, P A Krasilnikoff.   

Abstract

The aim of this study was to provide detailed information about the local and systemic antibody response and their relationship following a rotavirus gastroenteritis. Rotavirus-specific immunoglobulins were analyzed by enzyme-linked immunosorbent assay (ELISA). The study included 49 children referred to hospital with rotavirus gastroenteritis and 16 children with nonrotavirus gastroenteritis. The concentrations of rotavirus immunoglobulin A (IgA) in serum increased within the first 2 weeks and those of rotavirus IgG within the first month after the onset of diarrhea. Thereafter, they remained unchanged during the 6-month observation period. Rotavirus ScIg (i.e., antirotavirus immunoglobulin-containing secretory component) appeared in serum almost exclusively within 7-14 days after onset (i.e., 85% of the samples). After the first 2 weeks, rotavirus IgA could be detected in the majority of fecal samples, even up to 6 months after the disease. However, rotavirus ScIg was absent in the majority of fecal samples. The severity of illness correlated only with the increase of rotavirus IgG in serum. Conclusively, there is a longstanding immune response after a naturally acquired rotavirus gastroenteritis. Moreover, with the present methods, measurements of rotavirus IgA and IgG in serum can be safely used for serodiagnosis, even when samples are taken with 6-month interval. It is suggested that trials with rotavirus vaccines include measurements of rotavirus IgA and ScIg in serum and rotavirus IgA in feces.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944746     DOI: 10.1097/00005176-198601000-00014

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  13 in total

1.  Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.

Authors:  A Ferguson; K A Humphreys; N M Croft
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

2.  Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

Authors:  Daniel Herrera; Camilo Vásquez; Blaise Corthésy; Manuel A Franco; Juana Angel
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

3.  Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.

Authors:  K Midthun; L Z Pang; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

4.  Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection.

Authors:  K Johansen; L Granqvist; K Karlén; G Stintzing; I Uhnoo; L Svensson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Serologic and mucosal immune response to rotavirus infection in the rabbit model.

Authors:  M E Conner; M A Gilger; M K Estes; D Y Graham
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 7.  Human viral gastroenteritis.

Authors:  M L Christensen
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 8.  Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries.

Authors:  Laura M Lamberti; Christa L Fischer Walker; Robert E Black
Journal:  BMC Public Health       Date:  2012-04-06       Impact factor: 3.295

Review 9.  Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.

Authors:  Juana Angel; A Duncan Steele; Manuel A Franco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 10.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.